MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - Prognosis and prediction of outcome Biomarkers ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by